Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2020

Autorização de Utilização Excecional do medicamento

Contract value
€3,356.56
Signed on
16 December 2020
Procedure
Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 10765548

PUBLISHED SUBJECT

61/8038/2020 - Autorização de Utilização Excecional do medicamento

Parties involved

Awardee
Direcção-Geral dos Impostos - Intercomunitário RITI; - - RXSOURCE LIMITED; RB PRODUTOS FARMACÊUTICOS, UNIPESSOAL LDA; DUXPHARMA; - - Farma Mondo SA; - - CLINIGEN IRELAND LIMITED
Place of performance
Portugal, Faro
NUTS region
PT150 - Algarve

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
- - RXSOURCE LIMITED
Awardee
DUXPHARMA · Tax ID 510803679
Awardee
- - Farma Mondo SA
Awardee
- - CLINIGEN IRELAND LIMITED

Values and timeline

Contract price
€3,356.56
Procedure base price
€3,356.56
Total effective price
Not reported on Portal BASE
Publication date
13 June 2024
Award date
16 December 2020
Signing date
16 December 2020
Performance period
15 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Melhor relação qualidade – preço
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 24.º, n.º 4 do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
7088812

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts